StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
15
This year
1
Publishing Date
2024 - 03 - 25
1
2023 - 09 - 06
2
2023 - 07 - 03
1
2023 - 06 - 14
1
2022 - 12 - 20
1
2022 - 11 - 02
1
2022 - 05 - 31
1
2022 - 05 - 27
1
2022 - 04 - 13
1
2022 - 03 - 02
1
2022 - 03 - 01
1
2021 - 11 - 19
1
2021 - 10 - 27
1
2021 - 07 - 19
1
Sector
Health technology
15
Tags
Agreement
3
Alliances
1
Alymsys
2
Application
5
Approval
15
Australia
1
Authorized
1
Bijuva
1
Bioscience
1
Biosimilar
6
Biotech
1
Business
1
Ceo
1
China
1
Clinical-trials-phase-iii
2
Conference
6
Disease
5
Drug
5
Earnings
14
Esg
1
Events
10
Fda
15
Fda-approvals
6
Financial
6
Financial results
5
First
2
Fylnetra
1
Global
2
Growing
1
Growth
1
Health
1
Hiv
2
Injection
3
Innovation
1
Integration
1
Ipx-203
1
Ipx203
7
J.p. morgan healthcare conference
1
Legal
1
License
2
Lyvispah
1
Market
4
Mergers-and-acquisitions
1
N/a
14
Parkinson
2
Parkinson’s
3
Patent
2
People
4
Pharm-country
26
Pharmaceutical
4
Phase 3
3
Report
14
Research
8
Response
3
Results
29
Rtu
2
Therapeutics
3
Treatment
3
Trial
3
Year
4
Entities
Amneal pharmaceuticals, inc.
15
Symbols
ABBV
37
ABT
24
ADCT
19
ADMA
17
AGIO
11
ALNY
13
AMGN
22
AMPH
9
AMRX
15
ANIP
17
ARGX
10
ARVL
14
ATLC
8
AVEO
20
BCRX
16
BGNE
25
BHC
8
BIIB
20
BMY
48
BPMC
23
BSX
8
CALT
8
CLVS
19
CNSP
11
EPZM
18
EXEL
14
FNCTF
21
FRG
15
GH
12
GILD
16
GSK
10
HALO
9
ILMN
12
IMAB
8
INCY
41
JAGX
8
JAZZ
8
JNJ
94
KMDA
11
KPTI
31
LLY
46
LTUM
11
MDT
28
MRK
8
NVAX
10
NVS
21
NVSEF
13
PFE
31
PRGO
21
REGN
32
RETA
9
RIGL
11
SNY
97
SNYNF
63
TAK
20
TEVJF
13
VRTX
8
VSTM
10
VTRS
8
YMAB
19
Exchanges
Nyse
15
Crawled Date
2024 - 03 - 25
1
2023 - 09 - 06
2
2023 - 07 - 03
1
2023 - 06 - 14
1
2022 - 12 - 20
1
2022 - 11 - 02
1
2022 - 05 - 31
1
2022 - 05 - 27
1
2022 - 04 - 13
1
2022 - 03 - 02
1
2022 - 03 - 01
1
2021 - 11 - 19
1
2021 - 10 - 27
1
2021 - 07 - 19
1
Crawled Time
11:00
1
12:20
1
14:00
2
14:15
1
17:00
1
19:00
1
21:00
3
22:00
4
23:00
1
Source
www.biospace.com
15
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Approval
symbols :
AMRX
save search
Amneal Receives U.S. FDA Approval for Ciprofloxacin and Dexamethasone Otic Suspension
Published:
2024-03-25
(Crawled : 23:00)
- biospace.com/
AMRX
|
$5.435
1.21%
110K
|
Health Technology
|
-11.53%
|
O:
0.0%
H:
0.33%
C:
-2.64%
fda
approval
Amneal Receives U.S. FDA Approval for Calcium Gluconate Injection
Published:
2023-09-06
(Crawled : 22:00)
- biospace.com/
AMRX
|
$5.435
1.21%
110K
|
Health Technology
|
40.58%
|
O:
3.14%
H:
0.0%
C:
-6.09%
fda
approval
injection
Amneal Receives U.S. FDA Approval for Lisdexamfetamine Dimesylate
Published:
2023-09-06
(Crawled : 14:00)
- biospace.com/
AMRX
|
$5.435
1.21%
110K
|
Health Technology
|
40.58%
|
O:
3.14%
H:
0.0%
C:
-6.09%
fda
approval
Amneal Launches Authorized Generic for Xyrem® (sodium oxybate) and Receives FDA Approval for Five Complex Generics in the Second Quarter
Published:
2023-07-03
(Crawled : 22:00)
- biospace.com/
AMRX
|
$5.435
1.21%
110K
|
Health Technology
|
73.23%
|
O:
-2.26%
H:
0.66%
C:
0.66%
xyrem
fda
authorized
approval
Amneal Receives 505(b)(2) NDA Approval from FDA for PEMRYDI RTU®, a Ready-to-Use Oncology Injectable
Published:
2023-06-14
(Crawled : 22:00)
- biospace.com/
AMRX
|
$5.435
1.21%
110K
|
Health Technology
|
108.14%
|
O:
2.33%
H:
4.17%
C:
1.14%
rtu
fda
approval
Amneal Announces 26 Generic New Product Launches in 2022 and First Injection Large Volume Bag Approval
Published:
2022-12-20
(Crawled : 17:00)
- biospace.com/
AMRX
|
$5.435
1.21%
110K
|
Health Technology
|
148.61%
|
O:
-0.46%
H:
0.47%
C:
-2.33%
approval
injection
Amneal Receives FDA Approval for Leuprolide Acetate Injection
Published:
2022-11-02
(Crawled : 12:20)
- biospace.com/
AMRX
|
$5.435
1.21%
110K
|
Health Technology
|
130.47%
|
O:
0.86%
H:
0.0%
C:
-10.21%
fda
approval
injection
Kashiv Biosciences Achieves Second U.S. Biosimilar Approval with FYLNETRA® (pegfilgrastim-pbbk)
Published:
2022-05-31
(Crawled : 21:00)
- biospace.com/
AMRX
|
$5.435
1.21%
110K
|
Health Technology
|
55.2%
|
O:
-0.87%
H:
0.0%
C:
0.0%
fylnetra
biosimilar
approval
Amneal Achieves Third U.S. Biosimilar Approval with FYLNETRA™ (pegfilgrastim-pbbk)
Published:
2022-05-27
(Crawled : 11:00)
- biospace.com/
AMRX
|
$5.435
1.21%
110K
|
Health Technology
|
55.43%
|
O:
1.88%
H:
0.71%
C:
-1.7%
biosimilar
approval
Amneal Achieves Second U.S. Biosimilars Approval with ALYMSYS® (bevacizumab-maly)
Published:
2022-04-13
(Crawled : 21:00)
- biospace.com/
AMRX
|
$5.435
1.21%
110K
|
Health Technology
|
25.17%
|
O:
-0.7%
H:
6.46%
C:
1.88%
alymsys
approval
Kashiv Biosciences Receives Approval for Its First Biosimilar RELEUKOTM (filgrastim-ayow)
Published:
2022-03-02
(Crawled : 19:00)
- biospace.com/
AMRX
|
$5.435
1.21%
110K
|
Health Technology
|
17.25%
|
O:
-7.42%
H:
1.89%
C:
-5.19%
approval
bioscience
hiv
biosimilar
Amneal Enters U.S. Biosimilars Market With Approval of RELEUKOTM (filgrastim-ayow)
Published:
2022-03-01
(Crawled : 22:00)
- biospace.com/
AMRX
|
$5.435
1.21%
110K
|
Health Technology
|
18.54%
|
O:
1.1%
H:
0.0%
C:
0.0%
approval
biosimilar
Amneal Receives Approval for Difluprednate Ophthalmic Emulsion
Published:
2021-11-19
(Crawled : 14:00)
- biospace.com/
AMRX
|
$5.435
1.21%
110K
|
Health Technology
|
16.99%
|
O:
-1.31%
H:
4.08%
C:
1.99%
approval
ophthalmic emulsion
Amneal Launches Generic Dexamethasone Following ANDA Approval by FDA
Published:
2021-10-27
(Crawled : 14:15)
- biospace.com/
AMRX
|
$5.435
1.21%
110K
|
Health Technology
|
-3.07%
|
O:
-0.72%
H:
0.0%
C:
-2.91%
fda
approval
Amneal Receives Approval for Generic TobraDex®
Published:
2021-07-19
(Crawled : 21:00)
- biospace.com/
AMRX
|
$5.435
1.21%
110K
|
Health Technology
|
24.59%
|
O:
-2.09%
H:
2.37%
C:
2.37%
approval
Gainers vs Losers
89%
11%
Top 10 Gainers
MTTR
|
News
M
|
$4.65
167.24%
9.8M
|
AGBA
|
$2.46
96.8%
28M
|
Finance
EDBL
|
News
|
$6.94
84.57%
1.4M
|
CZOO
|
$7.74
55.11%
2.7M
|
VNRX
|
$0.84
40.0%
2.6M
|
Health Technology
OPRT
|
News
|
$3.01
33.78%
6.8M
|
Finance
MLEC
|
$1.81
29.29%
2M
|
n/a
MTC
|
$2.0
28.21%
1.7M
|
Technology Services
PEGY
|
$0.0586
27.95%
130M
|
Manufacturing
BTCM
|
$3.41
26.3%
230K
|
Arts, Entertainment, and Recrea...
Your saved searches
Save your searches and get alerts when important news are released.